Aktiesnakken — Marts 2011
-
-
-
Gorm du må gerne uddybe det med at belinostat kan udskrive til andre indikationer?
-
Det er forbudt at markedsføre et stof i indikationer som ikke er godkendt
-
-
Ja gorm offlabel brug er altid en mulighed. Men det er samtidigt også komplet umuligt at forudsige et omfang
-
jeg bryder mig ikke så meget om denne sætning " it is likely that this drug will be approved by the end of 2012 by the FDA"
-
der er stadig stor usikkerhed om stoffet bliver godkendt. SPA eller ej så er sandsynligheden pt ca 50%
-
så det er derfor vigtigt folk de investere i Topo er helt klart over risikoen
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind